Previous Article | Next Article ![]()
Infection and Immunity, March 2005, p. 1890-1894, Vol. 73, No. 3
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.3.1890-1894.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Infectious Disease Research Institute,1 Department of Pathology, Children's Hospital and Regional Medical Center, Seattle, Washington2
Received 15 September 2004/ Returned for modification 22 October 2004/ Accepted 11 November 2004
Mechanisms of natural killer T (NKT)-cell activation remain unclear. Here, we report that during Trypanosoma cruzi infection, interleukin-12 (IL-12) deficiency or anti-CD1d antibody treatment prevents normal activation. The required IL-12 arises independently of MyD88. The data support a model of normal NKT-cell activation that requires IL-12 and TCR stimulation.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|